BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4730599)

  • 1. Epithioandrostanol on mammary tumors of rats and mice.
    Takatani O; Kumaoka S; Yamaguchi K
    Gan; 1973 Jun; 64(3):305-7. PubMed ID: 4730599
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of mepitiostane on the growth of mammary tumor of a rat.
    Takatani O; Kumaoka S
    Gan; 1977 Jun; 68(3):337-41. PubMed ID: 913955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effect of two oral steroids, mepitiostane and fluoxymesterone, on a pregnancy-dependent mouse mammary tumor (TPDMT-4).
    Matsuzawa A; Yamamoto T
    Cancer Res; 1977 Dec; 37(12):4408-15. PubMed ID: 922732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Criteria for evaluating hormones in the 7,12-dimethylbenz[a]-anthracene-induced mammary tumor-rat experimental chemotherapy system.
    Teller MN; Kaufman RJ; Stock CC; Bowie M
    Cancer Res; 1968 Feb; 28(2):368-71. PubMed ID: 5694312
    [No Abstract]   [Full Text] [Related]  

  • 5. [Estrogenic and antineoplastic activity of a series of transformed analogs of estrone and estradiol].
    Sorokina IB; Barkova TI; Zakharychev AA; Chigir' RN; Ananchenko SN
    Izv Akad Nauk SSSR Biol; 1973; 5():664-70. PubMed ID: 4761310
    [No Abstract]   [Full Text] [Related]  

  • 6. 2Alpha, 3alpha-epithio-5alpha-androstan-17beta-YL 1-methoxycyclopentyl ether (10364-S), a new orally active anti-estrogenic steroid.
    Miyake T; Hori T; Kato G; Ide M; Uchida N; Yamaguchi K
    Steroids; 1974 Jun; 23(6):929-37. PubMed ID: 4836439
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental study on the establishment of a mammary adenocarcinoma MA--737 (author's transl)].
    Sun WY; Ma KS; Guan JF
    Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):168-73. PubMed ID: 7227180
    [No Abstract]   [Full Text] [Related]  

  • 8. 2 ,3 - Epithio-5 -androstan-17 -ol in the treatment of advanced breast cancer.
    Fujimori M
    Cancer; 1973 Apr; 31(4):789-92. PubMed ID: 4574661
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment in vivo of R3230AC carcinoma of the rat with estradiol mustard (NSC-112259) of its molecular components.
    Everson RB; Hall TC; Wittliff JL
    Cancer Chemother Rep; 1973; 57(3):353-5. PubMed ID: 4751260
    [No Abstract]   [Full Text] [Related]  

  • 10. Can neo-adjuvant chemotherapy prevent residual tumors?
    Bourut C; Chenu E; Mathé G
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():59-63. PubMed ID: 2977811
    [No Abstract]   [Full Text] [Related]  

  • 11. The mode of action of the antitumour agent GP 48,989 in the rat.
    Jordan VC; Dixon B; Prestwich G; Furr BJ
    Eur J Cancer (1965); 1979 May; 15(5):755-61. PubMed ID: 510337
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of medroxyprogesterone acetate and doxorubicin on sublines of 13762 mammary adenocarcinoma in rats.
    Formelli F; Zaccheo T; Casazza AM; Bellini O; Di Marco A
    Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1211-21. PubMed ID: 6460631
    [No Abstract]   [Full Text] [Related]  

  • 13. Observations on the hormone sensitivity of 7,12-dimethylbenz(alpha)anthracene-induced mammary tumors in the Sprague-Dawley rat.
    Griswold DP; Green CH
    Cancer Res; 1970 Mar; 30(3):819-26. PubMed ID: 5463906
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of hydroxyurea on growth of a transplantable mouse mammary adenocarcinoma.
    Lerner LJ; Bianchi A; Dzelzkalns M
    Cancer Res; 1966 Nov; 26(11):2297-300. PubMed ID: 5956633
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo metabolism of testosterone-3H in R-3327, an androgen-sensitive rat prostatic adenocarcinoma.
    Voigt W; Dunning WF
    Cancer Res; 1974 Jun; 34(6):1447-50. PubMed ID: 4826510
    [No Abstract]   [Full Text] [Related]  

  • 16. [A method of testing the antitumor effectiveness of drugs on induced rat mammary gland cancer].
    Beskrovnyĭ AM
    Vopr Onkol; 1970; 16(8):62-6. PubMed ID: 5501884
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibited growth in vivo of a mouse pregnancy-dependent mammary tumor (TPDMT-4) by an antiestrogen, 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (10275-S).
    Matsuzawa A; Yamamoto T
    Cancer Res; 1976 May; 36(5):1598-606. PubMed ID: 178425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9 Alpha-fluoro-11 beta-hydroxybenzo (d,e)testosterone 17-acetate. A modified steroid highly active on DMBA-induced mammary tumors in rats.
    Briziarelli G; Castelli PP; Vitali R; Gardi R
    Experientia; 1973 May; 29(5):618-9. PubMed ID: 4730311
    [No Abstract]   [Full Text] [Related]  

  • 19. Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
    Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA
    Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental research in the influence of the endocrine status on the antiblastic activity of cytostatics.
    Zimel H
    Neoplasma; 1967; 14(4):345-52. PubMed ID: 6063010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.